Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other Non-Current Assets (2020 - 2025)

Oncology Institute (TOI) has disclosed Other Non-Current Assets for 5 consecutive years, with $586000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets changed 0.34% year-over-year to $586000.0, compared with a TTM value of $586000.0 through Sep 2025, changed 0.34%, and an annual FY2024 reading of $589000.0, up 4.99% over the prior year.
  • Other Non-Current Assets was $586000.0 for Q3 2025 at Oncology Institute, roughly flat from $586000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $875000.0 in Q4 2021 and bottomed at $477000.0 in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $588230.8, with a median of $582000.0 recorded in 2024.
  • The sharpest move saw Other Non-Current Assets crashed 45.49% in 2022, then rose 17.61% in 2023.
  • Year by year, Other Non-Current Assets stood at $875000.0 in 2021, then plummeted by 45.49% to $477000.0 in 2022, then increased by 17.61% to $561000.0 in 2023, then increased by 4.99% to $589000.0 in 2024, then decreased by 0.51% to $586000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for TOI at $586000.0 in Q3 2025, $586000.0 in Q2 2025, and $591000.0 in Q1 2025.